FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA De Novo Authorization for Hep C Test

[ Price : $8.95]

FDA grants a de novo marketing authorization to Cepheid for its Xpert HCV test and GeneXpert Xpress System for detecting hepatitis...

PZAD Designation, Review Process Guidance

[ Price : $8.95]

FDA publishes a guidance to help sponsors pursue Priority Zoonotic Animal Drug designation for a new animal drug.

Guidance on Study Underrepresentation Diversity Plans

[ Price : $8.95]

FDA publishes a draft guidance on the content and format of certain diversity action plans intended to increase clinical study enr...

Verona Gets Ohtuvayre Approval for COPD

[ Price : $8.95]

FDA approves a Verona Pharma NDA for Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disea...

BrainStorm Gets FDA Alignment on CMC Issues

[ Price : $8.95]

BrainStorm Cell Therapeutics says it has reached alignment with FDA on chemistry, manufacturing, and controls aspects of the compa...

CDRH Joins Gates Foundation on Analytic Methods

[ Price : $8.95]

CDRH says it is partnering with the Bill and Melinda Gates Foundation and the National Institute for Standards and Technology on a...

Info Collection on Device TAP Pilot

[ Price : $8.95]

Federal Register notice: FDA submits to OMB a proposed information collection entitled Voluntary Total Product Life Cycle (TPLC) A...

Comments Sought on IT and Customer Strategy

[ Price : $8.95]

Federal Register notice: FDA requests comments on its Information Technology Strategy and Customer Experience Strategy.

Tempus AI Device for Atrial Fibrillation

[ Price : $8.95]

FDA clears a Tempus AI 510(k) for its Tempus ECG-AF device that uses artificial intelligence to help identify patients at increase...

Fujifilm New CT System Cleared

[ Price : $8.95]

FDA clears a Fujifilm Healthcare Americas 510(k) for its new compact, 128-slice computed tomography (CT) system, the FCT iStream.